日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Research progress on the correlation between blood pressure variability and hypertensive microvascular disease

血压变异性与高血压微血管疾病相关性研究进展

Chen, Shifeng; Kuang, Hongyu; Zhu, Jie; Wei, Jia; Pan, Pei; Hu, Xinyu; Yang, Ke; Yi, Xiaoshu; Du, Huaan

Kaempferitrin Attenuates Lipopolysaccharide-Induced Cardiac Dysfunction Through Suppression of the NF-κB/NLRP3 Signaling Pathway.

山奈酚苷通过抑制 NF-κB/NLRP3 信号通路减轻脂多糖诱导的心脏功能障碍。

Kuang Hongyu, Li Qiang, Chen Min, Du Huaan

Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial

达格列净联合热量限制治疗2型糖尿病缓解:一项多中心、双盲、随机、安慰剂对照试验

Liu, Yuejun; Chen, Ying; Ma, Jianhua; Lin, Jiayang; Liu, Changqin; Li, Xuejun; Xu, Yong; Kuang, Hongyu; Shi, Lixin; Xue, Yaoming; Feng, Bo; Zhu, Dalong; Wang, Guang; Yang, Jinkui; Xiao, Xinhua; Yu, Xuefeng; Zhou, Jiaqiang; Bao, Yuqian; Su, Qing; Lyu, Minzhi; Li, Xiaomu; Zhang, Huijie; Li, Xiaoying

From bench to bedside: elucidating VEGF(R) inhibitor-related heart failure in cancer treatment

从实验室到临床:阐明癌症治疗中 VEGF(R) 抑制剂相关的心力衰竭

Peng, Shengkun; Cai, MinHong; Kuang, Hongyu; Lin, Anqi; Ma, Qinghua; Dai, Xiaoqin; Luo, Peng; Liu, Yijun; Zhang, Guo; Bai, Yifeng

Sodium Glucose Transporter 2 Inhibitor Protects Against Heart Failure With Preserved Ejection Fraction: Preclinical "2-Hit" Model Reveals Autophagy Enhancement Via AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Complex 1 Pathway

钠-葡萄糖协同转运蛋白2抑制剂可预防射血分数保留型心力衰竭:临床前“二次打击”模型揭示其通过AMP激活蛋白激酶/雷帕霉素靶蛋白复合物1通路增强自噬

Hu, Xinyu; Li, Dan; Chen, Weijie; Kuang, Hongyu; Yang, Dan; Gong, Zhiyan; Long, Yuxiang; Liu, Guangliang; Wang, Kai; Xia, Mengshi; Xu, Yanping; Yin, Yuehui

Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial

金利达用于糖耐量受损和多种代谢异常患者糖尿病预防:FOCUS随机临床试验

Ji, Hangyu; Zhao, Xuefei; Chen, Xinyan; Fang, Hui; Gao, Huailin; Wei, Geng; Zhang, Min; Kuang, Hongyu; Yang, Baijing; Cai, Xiaojun; Su, Yanjin; Piao, Chunli; Zhao, Shuyu; Li, Liyang; Sun, Wenliang; Xu, Tianshu; Xu, Qinghua; Fan, Yuan; Ye, Jianhua; Yao, Chen; Shang, Meixia; Song, Guangyao; Chen, Liming; Zheng, Qingshan; Xiao, Xinhua; Yan, Li; Lian, Fengmei; Tong, Xiaolin; Jia, Zhenhua

Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models

对VEGF/VEGFR抑制剂诱导的免疫介导性高血压进行综合分析:整合药物警戒、临床数据和临床前模型

Kuang, Hongyu; Yan, Qingkai; Li, Zhanzhi; Lin, Anqi; Li, Kailai; Zhang, Jian; Luo, Peng; Yin, Yuehui

Independent risk factors of left ventricular hypertrophy in non-diabetic individuals in Sierra Leone - a cross-sectional study

塞拉利昂非糖尿病患者左心室肥厚的独立危险因素——一项横断面研究

Xu, Yuanxin; Jiang, Yingxin Celia; Xu, Lihua; Zhou, Weiyu; Zhang, Zhiying; Qi, Yanfei; Kuang, Hongyu; Yan, Shuang

The specific medications for pulmonary arterial hypertension at functional class III to IV: a systematic review and meta-analysis

肺动脉高压功能分级III至IV级患者的特定药物治疗:系统评价和荟萃分析

Li, Qiang; Kuang, Hongyu; Yi, Qijian; Du, Huaan

Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients

口服葡萄糖耐量试验中C肽曲线下面积与2型糖尿病患者糖尿病视网膜病变的相关性

Zhang, Cong; Ma, Xuefei; Lin, Wenjian; Xu, Qian; Li, Hongxue; Xu, Chengye; Hao, Ming; Kuang, Hongyu